8026
M. N. Elinson et al. / Tetrahedron 62 (2006) 8021–8028
4.2. General electrolysis procedure
2.94–3.18 (m, 2H), 3.20 (s, 3H, OCH3), 3.22 (s, 3H,
OCH3), 3.72–3.90 (m, 3H), 4.18 (q, 2H, J¼7.1 Hz). 13C
NMR (CDCl3): d 14.3 (CH3), 27.0 (CH2), 40.2 (CH2), 46.3
(CH2), 47.4 (OCH3), 47.6 (OCH3), 61.1 (OCH2), 66.33
(OCH), 98.84 [C(OCH3)2], 156.10 (C]O). MS (70 eV)
m/z (relative intensity %): 233 (M+, 20), 218 (8), 204 (16),
202 (11), 173 (15), 160 (18), 156 (21), 144 (43), 101 (57),
88 (100), 56 (67), 42 (98). IR (KBr): nmax 3460, 2944,
2832, 1685, 1436, 1272, 1228, 1120, 1076, 940.
A solution of ketone (10 mmol), sodium halide (10 mmol)
and base (type of the base and amount used are specified
in the corresponding Tables 1–4) in methanol or ethanol
(20 ml) was electrolyzed in an undivided cell equipped
with C-anode and Fe-cathode at 30 ꢁC under constant cur-
rent density 200 mA/cm2 until the quantity of the electricity
indicated in tables was passed. The reaction mixture was
neutralized by dilute HCl, the solvent was then removed,
and the reaction mixture was extracted with ether, washed
with solution of Na2S2O3 in water, then with water, and dried
over Na2SO4. Solvent was removed and then products were
isolated by sublimation (3a and 3b), vacuum distillation
(mixture of 6a and 7a, 6b) or column chromatography on
silica gel (eluent: hexane/ethyl acetate 1:1–10:1) (3c, 3d,
9, 10 and 11). Mixtures of 6a and 7a were converted into
6a by hydrogenation.
4.3.4. tert-Butyl 3-hydroxy-4,4-dimethoxypiperidine-1-
carboxylate (3d).23 Compound 3d was isolated by column
chromatography (eluent: hexane/ethyl acetate 1:1), yield
1
1.35 g (52%), colourless oil, H NMR (CDCl3): d 1.40 (s,
9H), 1.71–1.86 (m, 2H), 2.65 (s, 1H, OH), 2.95 (m, 1H),
3.15 (s, 3H, OCH3), 3.18 (s, 3H, OCH3), 3.29 (m, 1H),
3.61–3.73 (m, 3H). 13C NMR (CDCl3): d 28.1 (CH3), 28.4
(CH2), 42.2 (CH2), 47.5 (OCH3), 47.6 (OCH3), 48.47
(CH2), 65.86 (OCH), 79.12 (C–O), 99.92 [C(OCH3)2],
154.56 (C]O). MS (70 eV) m/z (relative intensity %): 261
(M+, 2), 204 (5), 188 (2), 160 (4), 146 (14), 101 (15), 89
(24), 57 (100), 43 (66). IR (KBr): nmax 3400, 2944, 2832,
1692, 1428, 1368, 1172, 1120, 1076, 940.
4.3. General hydrogenation procedure
Mixtures of 6a and 7a (0.5 g–2.0 g) in 20 ml of MeOH in the
presence of 0.12 g, 5% Pd/C catalyst was hydrogenated in
steel autoclave equipped with magnetic stirrer (500 rounds
per minute) under 20 bar of hydrogen pressure during 5 h.
Conversion of 7a into 6a was controlled by GC analysis
on 11 mꢂ0.25 mm Supelco SPÔ 2380 capillary column
(column temperature 120 ꢁC). After 5 h compound 7a was
fully converted into 6a with quantitative yield. The catalyst
was filtered off, and after solvent removing 6a was isolated.
4.3.5. Methyl 2,2,5,5-tetramethyl-3-pyrrolidinecarboxyl-
ate (6a).31,32 Yield 1.26 g (70%) [two-step procedure: elec-
trolysis (exp.10, Table 2) and hydrogenation], colourless oil,
bp 96–99 ꢁC (14 Torr), [lit.33 bp 86 ꢁC (10.5 Torr)], 1H NMR
(CDCl3): d 1.10 (s, 3H, CH3), 1.22 (s, 3H, CH3), 1.31 (s, 3H,
CH3), 1.40 (s, 3H, CH3), 1.91 (dd, 1H, J1¼7.3 Hz,
J2¼13.1 Hz), 2.19 (dd, 1H, J1¼11.5 Hz, J2¼13.1 Hz), 2.88
4.3.1. 1-Benzyl-4,4-dimethoxypiperidine-3-ol (3a).23,28
Yield 1.78 g (71%) [exp. 6, Table 1], white solid, mp 89–
(dd, 1H, J1¼7.3 Hz, J2¼11.5 Hz), 3.65 (s, 3H, OCH3). 13
C
NMR (CDCl3): d 25.9 (CH3), 30.8 (CH3), 31.0 (CH3), 31.3
(CH3), 42.4 (CH2), 51.2 (OCH3), 54.7 (CH), 57.5 (C), 62.0
(C), 173.2 (C]O). MS (70 eV) m/z (relative intensity %):
185 (M+, 4), 170 (100), 154 (11), 138 (14), 124 (10), 110
(45), 99 (33), 84 (24), 58 (98). IR (KBr): nmax 2964, 2930,
2872, 1736, 1464, 1436, 1368, 1288, 1188, 1148.
1
90 ꢁC, H NMR (CDCl3): d 1.75–2.0 (m, 2H), 2.12–2.25
(m, 1H), 2.50–2.56 (m, 1H), 2.65–2.75 (m, 1H), 2.74 (s,
1H, OH), 2.83–2.90 (m, 1H), 3.22 (s, 3H, OCH3), 3.28 (s,
3H, OCH3), 3.57 (s, 2H, CH2Ph), 3.70–3.74 (m, 1H, CH–
O), 7.25–7.38 (m, 5H, Ph). 13C NMR (CDCl3): d 27.8
(CH2), 47.5 (OCH3), 47.6 (OCH3), 49.2 (CH2), 56.1
(CH2), 61.9 (CH2), 66.8 (OCH), 98.9 [C(OCH3)2], 127.0,
128.2, 128.8, 137.8 (Ph). MS (70 eV) m/z (relative intensity
%): 251 (M+, 12), 236 (14), 220 (23), 202 (15), 188 (10), 142
(6), 120 (21), 91 (100), 65 (15), 42 (17). IR (KBr): nmax 3450,
2912, 2832, 1584, 1452, 1340, 1212, 1132, 1076, 948.
4.3.6. Methyl 2,2,5,5-tetramethyl-2,5-dihydro-1H-pyr-
role-3-carboxylate (7a).26,32 Compound 7a was obtained
by method as described in Ref. 34. 70% Yield, colourless
oil, bp 110–112 ꢁC (15 Torr) [lit.34 bp 56–58 ꢁC
1
(1.3 Torr)], H NMR (CDCl3): d 1.29 (s, 6H), 1.40 (s, 6H),
3.71 (s, 3H, OCH3), 6.60 (s, 1H). 13C NMR (CDCl3):
d 29.7 (CH3), 29.8 (CH3), 51.0 (OCH3), 63.2 (C), 65.7 (C),
139.0 (C]), 148.9 (CH]), 164.3 (C]O). MS (70 eV)
m/z (relative intensity %): 183 (M+, 25), 168 (100), 152
(18), 136 (43), 122 (30), 108 (82), 94 (49), 67 (45). IR
(KBr): nmax 2964, 2928, 2872, 1730, 1632, 1436, 1368,
1328, 1148, 1064.
4.3.2. 1-Methyl-4,4-dimethoxypiperidine-3-ol (3b). Yield
1.41 g (81%), white solid, mp 108–109 ꢁC [lits.29,30 109–
1
110 ꢁC], H NMR (CDCl3): d 1.80–1.94 (m, 2H), 2.05–
2.13 (m, 1H), 2.25 (s, 3H, CH3), 2.38–2.43 (m, 1H),
2.58–2.65 (m, 1H), 2.76–2.81 (m, 1H), 2.85 (s, 1H, OH),
3.19 (s, 3H, OCH3), 3.25 (s, 3H, OCH3), 3.71–3.75 (m,
1H, CH–O). 13C NMR (CDCl3): d 27.5 (CH2), 45.5 (CH3),
47.5 (OCH3), 47.6 (OCH3), 51.6 (CH2), 58.2 (CH2), 66.9
(OCH), 98.5 [C(OCH3)2]. MS (70 eV) m/z (relative intensity
%): 175 (M+, 24), 160 (23), 144 (29), 126 (31), 112 (20), 100
(7), 87 (45), 70 (11), 58 (49), 44 (100). IR (KBr): nmax 3136,
2944, 2772, 1468, 1360, 1292, 1152, 1116, 1068, 948.
4.3.7. Ethyl 2,2,5,5-tetramethyl-3-pyrrolidinecarboxyl-
ate (6b).35 Compound 6b was isolated by reaction mixture
distillation (exp. 3, Table 3), 1.01 g (51%) colourless oil,
1
bp 114–116 ꢁC (15 Torr) [lit.35 bp 217 ꢁC (748 Torr)], H
NMR (CDCl3): d 1.07 (s, CH3), 1.20 (s, CH3), 1.25 (t, 3H,
J¼7.1 Hz), 1.29 (s, CH3), 1.39 (s, CH3), 1.89 (dd, 1H,
J1¼7.3 Hz, J2¼13.0 Hz), 2.15 (dd, 1H, J1¼11.6 Hz,
J2¼13.0 Hz), 2.85 (dd, 1H, J1¼7.3 Hz, J2¼11.6 Hz), 4.05–
4.20 (m, 2H). 13C NMR (CDCl3): d 14.1 (CH3), 25.9
(CH3), 30.9 (CH3), 31.1 (CH3), 31.4 (CH3), 42.4 (CH2),
54.9 (CH), 57.5 (C), 60.0 (OCH2), 62.0 (C), 172.73
4.3.3. Ethyl 3-hydroxy-4,4-dimethoxypiperidine-1-car-
boxylate (3c).28 Compound 3c was isolated by column
chromatography (eluent: hexane/ethyl acetate 1:1), yield
1
1.28 g (55%), colourless oil, H NMR (CDCl3): d 1.22 (t,
3H, J¼7.1 Hz), 1.65–1.88 (m, 2H), 2.65 (s, 1H, OH),